Neuropilin-1 is a valuable biomarker for predicting response of advanced non-small cell lung cancer patients to hypofractionated radiotherapy and PD-1 blockade-Reference-Cited by-同舟云学术

Neuropilin-1 is a valuable biomarker for predicting response of advanced non-small cell lung cancer patients to hypofractionated radiotherapy and PD-1 blockade

Published:2022-08 Issue: Volume:109 Page:108732
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Kang Pengyuan,Li Yunfei,Hu Zhi,Lei Ming,Cheng Jun,Guo Xiyuan,Zhang Lulu,Lin Sheng,Yuan Qing

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference44 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA Cancer J. Clin.,2021

2. The biology and management of non-small cell lung cancer;Herbst;Nature,2018

3. Five-Year Follow-Up of Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: Results from the CA209-003 Study;Gettinger;J. Clin. Oncol.,2018

4. TOX promotes the exhaustion of antitumor CD8(+) T cells by preventing PD1 degradation in hepatocellular carcinoma;Wang;J. Hepatol.,2019

5. The Integration of Radiotherapy with Immunotherapy for the Treatment of Non-Small Cell Lung Cancer;Ko;Clin. Cancer Res.,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spatiotemporal Profiling Unveiling the Cellular Organization Patterns and Local Protumoral Immune Microenvironment Remodeling in Early Lung Adenocarcinoma Progression;2023-11-01

2. Interleukin 8 in plasma is an efficacy marker for advanced non-small cell lung cancer treated with hypofractionated radiotherapy and PD-1 blockade;Cytokine;2023-03

3. Tracking Peripheral Memory T Cell Subsets in Advanced Nonsmall Cell Lung Cancer Treated with Hypofractionated Radiotherapy and PD-1 Blockade;Journal of Oncology;2023-01-31